As a technology and service provider to the biopharmaceutical industry, nanoPET Pharma focuses on the R&D, production as well as marketing of innovative agents for Diagnostic Imaging. The company offers an exciting product portfolio of specialized preclinical imaging agents covering the principal diagnostic modalities (MRI, CT, Ultrasound and Optical Imaging) under the brand name ViscoverTM (www.viscover .berlin). With more than 20 years experience in the field of diagnostic imaging, the company also offers consulting and contract research services. In addition, nanoPET Pharma pursues the clinical development of its patented core technology platform of inorganic nanoparticle PET tracers.